#SarcomaAwarenessMonth This month, we join the global sarcoma community in raising awareness for synovial sarcoma, a rare and aggressive form of cancer that primarily affects young adults in the prime of their lives. Learn more at curesarcoma.org and sarcomaalliance.org #SarcomaAwareness #Biotech #Innovation #Oncology #CancerCare
Adaptimmune’s Post
More Relevant Posts
-
Exploring the intricate connections between cancer and systemic elements, including the tumor microenvironment, may help broaden our therapeutic landscape beyond conventional targeting. Explore Eisai’s global pipeline to learn more: https://ow.ly/zwfu50RZe7K #oncology
To view or add a comment, sign in
-
The field of immuno-oncology has a transformative impact, across different cancer types, with many advancements made in recent years. With the potential to treat many patients who need it most, it is important to know the current trends in the immunooncology clinical trial space. Download our free white paper, authored by Graham Belgrave, to learn more: https://hubs.la/Q02lJnDV0 #immunooncology #oncology #clinicaltrials #clinicalresearch
To view or add a comment, sign in
-
-
Last week, Anixa Biosciences announced new and updated positive results from the Phase 1 clinical trial of our breast cancer vaccine, conducted in collaboration with our partner Cleveland Clinic. Anixa and Cleveland Clinic plan to investigate additional intermediate dose levels and continue studying the vaccine’s safety and immunologic effects in two additional patient cohorts. Read our press release for more details on the data: https://bit.ly/46UprZc #Science #Oncology #OncNews
To view or add a comment, sign in
-
Discover the latest advancements in PARP with our updated pipeline, now available as a downloadable PDF. Stay on top of the latest in cancer research and innovation with LARVOL. Learn more: https://bit.ly/3L20ORN #LARVOL #PARP #Oncology #CancerResearch #MedicalProgress #OncologyUpdates #CancerCare
To view or add a comment, sign in
-
The field of immuno-oncology has a transformative impact, across different cancer types, with many advancements made in recent years. With the potential to treat many patients who need it most, it is important to know the current trends in the immunooncology clinical trial space. Download our free white paper, authored by Graham Belgrave, to learn more: https://hubs.la/Q02z6pf20 #immunooncology #oncology #clinicaltrials #clinicalresearch
To view or add a comment, sign in
-
-
A promise we made and delivered! Introducing MS-AP-031 It is proven to delay #metastasis in #colorectalcancer patients! ✅ Check 👇 our case-study Follow Mestastop® Solutions to get more exciting news in the fight against cancer #nononcologydrugs #oncology #drugrepurposing #drugdevelopment #cancerdrug #cancertreatment #cancerresearch
To view or add a comment, sign in
-
Two #pelareorep abstracts are now live at #ASCO24. A trial-in-progress for GOBLET cohort 5 in #PancreaticCancer with lead author Dirk Arnold and supported by Pancreatic Cancer Action Network. The second discussing pelareorep's MOA and ability to expand TILs across multiple #cancer indications: https://lnkd.in/gSVrgW2R #ASCO #PancreaticCancerResearch #BreastCancer #BreastCancerResearch #CancerResearch #biotech #oncology #oncolytics
To view or add a comment, sign in
-
-
The high unmet medical need for early onset cancer has implications for the regulatory pathway and the perceived value of newly developed agents. Learn the nuanced considerations for developing and marketing a new treatment for cancer in younger adults in our upcoming webinar: https://ow.ly/hOzq50Qk9Er #earlyonsetcancer #oncology #drugdevelopment
To view or add a comment, sign in
-
-
An implication of the Cancer Moonshot initiative is new research studying the effectiveness of Multi-Cancer Detection tests. Learn more about the challenges and promise of these tests for early cancer detection. More to Learn: https://bit.ly/3SEFAOY #mcdtest #mcedtests #multicancersdetection #liquidbiopsy #bloodbiopsy #plasmabiopsy #oncology #earlycancerdetection #3stepsdetect #earlycancerdetection
To view or add a comment, sign in
-
-
Dr James Costin, Head of Research & Development, talks about how GP-2250 takes a unique path to battle #pancreaticcancer by blocking aerobic glycolysis enzymes and hydrogenase that fuel #cancer cells, it diminishes their energy, reducing metabolic and oxidative stress within these cells. To learn more about misetionamide (GP-2250) and make a difference in the fight against cancer visit: https://lnkd.in/e2g_RsyP #cancerresearch #oncology #cancerpatients
To view or add a comment, sign in